Clinical Report: Influenza Vaccine Dose and Dementia Outcomes

Overview

Revise to emphasize that the study provides Class II evidence but does not establish causality.

Background

Influenza vaccination is crucial for older adults, who are at increased risk for severe influenza-related complications. Understanding the impact of vaccine dosage on cognitive outcomes, such as dementia, is important for optimizing preventive strategies in this vulnerable population. This study explores the potential link between high-dose influenza vaccination and reduced risk of Alzheimer dementia.

Data Highlights

Key Findings

• High-dose influenza vaccine associated with lower Alzheimer dementia risk in older adults.
• Maximum absolute risk difference was approximately 0.5%, with an NNT of 185 at month 25.
• Risk ratios ranged from 0.78 to 0.89, indicating consistently lower risk with high-dose vaccination.
• Women showed a longer-lasting association compared to men.
• Secondary analyses indicated sustained seasonal high-dose vaccination also reduced dementia risk.
• Potential misclassification in claims-based data may affect findings.

Clinical Implications

Highlight the necessity for further research to confirm findings and clarify underlying mechanisms.

Conclusion

Reiterate the need for further investigation into the clinical significance of the findings.

References

1. Bukhbinder AS, Neurology, 2023 -- Influenza Vaccine Dose and Dementia Outcomes
2. Bukhbinder AS, Neurology, 2023 -- High-Dose Inactivated Influenza Vaccine Inconsistently Improves Heterologous Antibody Responses in an Older Human Cohort
3. Bukhbinder AS, Neurology, 2023 -- Comparative Effectiveness of High-Dose and Standard-Dose Influenza Vaccines on Hospitalization and Mortality Rates Based on Frailty Assessment
4. CDC, MMWR, 2025 -- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices
5. Age and Ageing, 2025 -- Influenza vaccination and risk of dementia: a systematic review and meta-analysis
6. The Journal of Infectious Diseases — Immune Responses of Antineuraminidase Antibodies in Elderly Individuals Following Sequential Administration of Advanced Influenza Vaccines: A Randomized Controlled Study
7. CDC Guidelines for Influenza Vaccination
8. Efficacy of High-Dose Influenza Vaccine
9. Influenza vaccination and risk of dementia: a systematic review and meta-analysis | Age and Ageing | Oxford Academic